BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Ambrx, Inc. 

10975 North Torrey Pines Road

La Jolla  California  92037  U.S.A.
Phone: 858-875-2400 Fax: 858-453-4511


SEARCH JOBS



Segment
Pharmaceuticals





 Company News
Sheila Gujrathi, M.D., Joins Ambrx, Inc. Board Of Directors 2/24/2014 7:34:13 AM    More...
Ambrx, Inc. Appoints Barry Greene To Board Of Directors 2/5/2014 8:51:09 AM    More...
Ambrx, Inc. Appoints Peter Kiener, Ph.D., as Chief Scientific Officer 8/20/2013 6:19:16 AM    More...
Week in Review: Zhejiang Medicine to Develop Ambrx, Inc. Breast Cancer Drug 6/24/2013 9:15:20 AM    More...
Ambrx, Inc. and Zhejiang Medicine Co. Ltd. Form Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugate for Breast Cancer 6/17/2013 11:16:28 AM    More...
Ambrx, Inc. and Zhejiang Medicine Co. Ltd. Form Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugate for Breast Cancer 6/17/2013 8:47:25 AM    More...
Bristol-Myers Squibb Company (BMY) Partners Again With Ambrx, Inc. in Up to $112 Million and Up ADC Collaboration 5/3/2013 7:19:51 AM    More...
Astellas Pharma Inc. (YPH.BE) Signs $300 Million Cancer Pact With Ambrx, Inc. 4/5/2013 7:49:05 AM    More...
Ambrx, Inc. Appoints Lawson Macartney, Ph.D., DVM, CEO 1/7/2013 6:48:52 AM    More...
Merck & Co., Inc. (MRK) Bets Up to $303 Million on Ambrx, Inc.'s "Smart Bomb" Antibodies 6/18/2012 6:38:52 AM    More...
1234

//-->